“Gas Station Heroin” Crackdown Grows: Connecticut Joins Dozens of States Banning Tianeptine amid Reports of Overdoses and Addiction
Tianeptine, dubbed “gas station heroin,” is an unapproved drug sold as supplements in stores and online. With opioid-like effects, it has caused addiction, overdoses and deaths, prompting state bans and federal warnings and emergency alerts.
Key takeaways
- Unapproved and dangerous: Tianeptine is not FDA-approved and is marketed illegally as supplements in pills, powders and liquids.
- Widespread regulatory action: At least 14 states have scheduled it as a controlled substance; Connecticut recently banned sale and use.
- Serious health risks: Low doses may cause euphoria; high doses act on mu-opioid receptors, risking respiratory depression, coma and death.
- Clinical and public-health challenge: Standard drug screens often miss it, complicating diagnosis, treatment and surveillance.
Key information
Tianeptine is a tricyclic antidepressant not approved by the U.S. Food and Drug Administration (FDA) for use in the United States. Despite that, it has been sold illegally as a “supplement” in pills, powders, salts and liquids under brand names such as Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red. (Sources: FDA, VCU Health, NCBI research news.)
Medical and regulatory background
In some countries, tianeptine is prescribed at low doses (typically 12.5–37.5 mg daily) for depression and related conditions, but the FDA has never approved it for any U.S. use. Products containing tianeptine have been marketed here for mood, energy and pain relief despite lacking proven safety or efficacy (Mayo Clinic).
State action accelerated as reports of harm rose. By 2025, numerous states moved to schedule or ban tianeptine; lawmakers in Congress have proposed federal restrictions to prohibit marketing nationally (see Rep. Pallone press release).
How tianeptine harms the body
Medical experts explain that tianeptine has dose-dependent effects: at lower amounts it increases serotonergic activity and can produce mild euphoria; at higher doses it stimulates mu-opioid receptors — the same pathway targeted by heroin and prescription opioids — which can suppress breathing and be fatal. Dr. Robert Schwaner, vice chair of system clinical affairs at Stony Brook Emergency Medicine, warned that:
“With increasing doses, the mu-opioid receptor stimulation may become lethal,” and significant stimulation can lead to respiratory arrest.
Reported adverse effects include agitation, confusion, severe sedation, respiratory depression, seizures, arrhythmia, high blood pressure, nausea, vomiting and death. Mixing tianeptine with opioids, benzodiazepines, alcohol or other depressants raises the risk of fatal overdose. Poison centers and hospitals in multiple states documented spikes in serious exposures and ICU-level cases in 2024 (New Jersey Health Alert, VCU Health, FDA).
Addiction and withdrawal
People who use large amounts can develop dependence and withdrawal symptoms similar to opioid withdrawal: intense cravings, sweating, diarrhea, muscle aches, anxiety and chills. Standard drug tests often do not detect tianeptine, which can delay diagnosis and complicate treatment (FDA, Mayo Clinic).
Marketing, availability and youth risk
Investigations show manufacturers and retailers marketed tianeptine with misleading claims that it relieves pain, lifts mood or sharpens focus. Products are sometimes candy-flavored with bright packaging, increasing appeal to young people. The FDA warned delayed recognition allowed these products to spread through convenience stores, gas stations, vape shops and online sellers before regulators acted. Connecticut Lt. Gov. Susan Bysiewicz called the scheduling change “a necessary step to combat addiction” and highlighted the threat to youth and people with substance-use disorder.
Recent clusters and investigations
Public health alerts documented localized clusters tied to brands. New Jersey officials linked severe poisonings and deaths to products labeled Neptune’s Fix and other street brands in 2024 (NJ Health Alert). Virginia poison centers reported ICU-level cases while clinicians worked to diagnose unexplained respiratory depression, helping drive state-level scheduling and enforcement actions (VCU Health).
Clinical recommendations and resources
Clinicians should ask about tianeptine when patients present with unexplained opioid-like symptoms. Overdose treatment follows standard protocols for opioid toxicity, but detection gaps and mixed exposures can complicate care. The FDA and poison centers advise avoiding products marketed as tianeptine supplements.
Help and emergency numbers: For substance-use help, call the SAMHSA National Helpline at 1-800-662-HELP (4357) or visit SAMHSA National Helpline. For suspected poisoning, call Poison Control at 1-800-222-1222.
Policy responses and national debate
Federal regulators and lawmakers voiced concern. FDA leadership issued alerts in 2025 about risks to youth and the broader public. Legislators such as Rep. Frank Pallone and Sen. Dick Durbin reintroduced bills aiming to prohibit marketing of tianeptine-containing products nationwide (Pallone press release). Experts urge national regulation to prevent further harm (NCBI).
Implications for San Diego, California
Public health and emergency care: San Diego hospitals already manage opioid overdoses. Tianeptine — which can be more potent than morphine at high doses — could increase the burden and requires clinician awareness of a drug not detected on routine screens (FDA).
Youth safety and schools: Candy-like flavors and retail availability may put teens at risk. County health and school officials may need targeted education and retailer outreach to limit sales to minors (FDA).
Law enforcement and retail oversight: If California does not enact a statewide ban, local enforcement and consumer-protection actions may be considered. Tracking local availability of brand names such as Tianaa, ZaZa, Neptune’s Fix can help regulators spot threats (VCU Health, NJ Health Alert).
Resources for residents: San Diegans can call SAMHSA National Helpline at 1-800-662-HELP or Poison Control at 1-800-222-1222 for assistance (SAMHSA).
Reporting on a moving threat
Public health officials note the trend expanded quickly because products were easy to buy and marketed deceptively. As states ban or schedule tianeptine and federal attention grows, clinicians, parents, retailers and lawmakers must decide on prevention, treatment and enforcement. Experts urge caution: avoid unapproved supplements, seek help for substance-use problems, and report suspect products to public health authorities (Mayo Clinic, NJ Health Alert).
Sources and further reading
- FDA: “New ‘Gas Station Heroin’ Tianeptine Product Trend”
- VCU Health: “What You Need to Know About Gas Station Heroin”
- NCBI research news
- New Jersey Health Alert: Tianeptine exposures
- Mayo Clinic overview
- Pallone press release on federal bill
- SAMHSA National Helpline
Reporting from Times Media Service; sources include FDA, state health alerts, academic and clinical reports listed above.
